US EditionNutriband Advances Abuse-Deterrent Pharmaceutical Technology
Summary by citybuzz.co
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Nutriband Advances Abuse-Deterrent Pharmaceutical Technology
Nutriband Inc. (NASDAQ: NTRB) is making significant strides in pharmaceutical innovation with its proprietary AVERSA abuse-deterrent technology, a breakthrough approach to enhancing drug safety in transdermal pharmaceutical products. The company’s primary focus is developing a portfolio of transdermal pharmaceutical products that can prevent drug abuse, misuse, diversion, and accidental exposure. Its lead product is an abuse-deterrent fentanyl p…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
